Navigation Links
Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc.
Date:6/18/2013

Mississauga, Ontario (PRWEB) June 18, 2013

Inflamax Research Inc., a full service CRO specializing in Proof of Concept and Phase I-IV clinical trials, announced today that they will have a strategic alliance with Northern Air Environmental Technologies (NAET), a specialty air conditioning & environmental control company, for the deployment, monitoring, and servicing of mobile Environmental Exposure Chambers (EECs) used in Allergy, Asthma, and Ocular clinical trials.

Inflamax Research has proprietary Next Generation Environmental Exposure Chamber technology and is a world leader in allergy and asthma research. Mobile EECs (mEEC™), a groundbreaking advancement developed by Inflamax Research, allow for the conduct of multi-center allergy and ocular clinical trials and show great promise in furthering allergy and asthma research by allowing study sites to be set up at targeted locations with a high prevalence of specific allergies, rather than having patients commute to a fixed EEC site. Northern Air will work exclusively with Inflamax Research to support mEEC™ multicenter clinical trials in the area of facility and mEEC™ design, construction, and maintenance.

This strategic partnership between Inflamax Research and Northern Air will expedite trial operationalization by contracting the oversight of custom built environmental control units (ECU) and air handling systems to a sole vendor. Northern Air is involved from point of conceptual design to remote deployment, and on-site validation.    

Inflamax Research will create the allergy models and Northern Air Environmental Technologies Inc. will custom-build the ECUs and supervise the air handling systems in Inflamax Research mEEC™. By having Northern Air as an exclusive vendor, Inflamax can focus on conducting the trials while being assured that the environmental control systems are being overseen by industry experts.

“I
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation.
2. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
3. Inflamax Research Appoints Dr. Anne Marie Salapatek President & Chief Scientific Officer
4. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
5. Inflamax Research announces the launch of its Mobile Environmental Exposure Chamber™ for conduct of Allergy & Asthma Trials
6. Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research
7. Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review
8. New Research On Stuttering Jul 2-3 At Arizona Symposium
9. UCSB researchers identify the mechanisms underlying salt-mediated behaviors in fruit flies
10. DNA Sequencing Market 2013 Developments & 2016 Product Forecasts in New Research Reports at ReportsnReports.com
11. David Julius Wins 2013 Dr. Paul Janssen Award for Biomedical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015   GenoSpace , a ... interpretation and analysis of genomic and other biomedical ... has joined the company as Vice President of ... http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace partners with ... interpret, analyze and explore complex sets of genomic, ...
(Date:7/30/2015)... ... ... The 2015 Market Research Report on the Global Propanol Industry ... market with a focus on the Chinese situation. Major companies included in the propanol ... Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report provides ...
(Date:7/30/2015)... ... July 30, 2015 , ... Leading ... clinical study of its canine osteoarthritis stem cell product, currently under development for ... KS) and will be marketed in the US by Aratana. This product, termed ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... BIOFUEL ENERGY CORP. (Nasdaq: BIOF ... 2010 results.  For the quarter ended September 30, 2010, revenues ... million, compared to revenues of $91.1 million and a net ...  Net loss attributable to common shareholders was $1.4 million, or ...
... can wear on your nerves, but it really does ... in automotive fuel cells. Before large fleets of fuel-cell-powered ... find a way to protect the platinum, the most ... amount needed to make catalytically active electrodes. Now, ...
... Corporation (Nasdaq: DNDN ) today announced ... post-approval supplement to the PROVENGE® (sipuleucel-T) Biologics License ... facility. Dendreon is requesting licensure for an additional ... Food and Drug Administration (FDA) review for a ...
Cached Biology Technology:BioFuel Energy Reports Third Quarter Results 2BioFuel Energy Reports Third Quarter Results 3BioFuel Energy Reports Third Quarter Results 4BioFuel Energy Reports Third Quarter Results 5New highly stable fuel-cell catalyst gets strength from its nano core 2New highly stable fuel-cell catalyst gets strength from its nano core 3Dendreon Submits Post-Approval Supplement to the PROVENGE Biologics License Application for New Jersey Manufacturing Facility 2
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... , GALVESTON, Texas Effective immediately, the University of ... for the United States Antarctic Program. UTMB will ... subcontractor for Lockheed Martin,s Antarctic Support Contract. ... Dr. David L. Callender, president of UTMB. "We are ...
... Wyss Institute for Biologically Inspired Engineering at Harvard ... a Cooperative Agreement worth up to $37 million ... to develop an automated instrument that integrates 10 ... the body. This effort builds on the ...
... at the University of Leicester has discovered that South Asians ... higher levels of blood sugar than white Europeans independent of ... of 4,688 white Europeans and 1,352 South Asians was led ... Department of Cardiovascular Sciences, and was published in Diabetes ...
Cached Biology News:University of Texas Medical Branch selected to manage Center for Polar Medical Operations 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 2Wyss Institute receives up to $37 million from DARPA to integrate organ chips to mimic the human body 3
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... EPICENTREs patented MasterAmp™ 10X PCR ... performance and allows improved sensitivity and ... templates. Using MasterAmp™ PCR Enhancer in ... of DNA melting, increases enzyme?s thermal ...
... simple three step procedure (PCR, Exonuclease III ... in one day. The typical cloning efficiency ... , Features and Benefits: , , Universal ... any expression vector , High Cloning Efficiency ...
Biology Products: